Romania vs Uruguay: HIV/AIDS deaths averted by antiretroviral therapy
Romania
514.7 deaths
in 2024
Uruguay
516 deaths
in 2022
Romania rank
92nd
Uruguay rank
91st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Romania
- Uruguay
How they compare
Uruguay currently reports 516 deaths against 514.7 deaths in Romania, a difference of 1.3 deaths.
The two have swapped places 2 times across 33 shared years of data; in 1990 it was Uruguay ahead.
Romania ranks 92nd and Uruguay ranks 91st of 157 countries.
Across the 4 decades both report, Romania averaged higher in 3 and Uruguay in 1.
Head to head by decade
| Decade | Romania | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 3.23 deaths | 25 deaths | 21.77 deaths | Uruguay |
| 2000s | 441.47 deaths | 166.5 deaths | 274.97 deaths | Romania |
| 2010s | 514.41 deaths | 364 deaths | 150.41 deaths | Romania |
| 2020s | 521.61 deaths | 487 deaths | 34.61 deaths | Romania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Romania or Uruguay?
- Uruguay, at 516 deaths against 514.7 deaths in Romania as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Romania and Uruguay?
- 1.3 deaths, with Uruguay ahead.
- How many years of comparable data are there for Romania and Uruguay?
- 33 years are reported by both, from 1990 to 2022.
- How do Romania and Uruguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Romania ranks 92nd and Uruguay ranks 91st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.